На главную
Результаты поиска “Pharmaceutical cost control generic drugs” за 2016
Why Are Prescription Drugs So Expensive?
» Subscribe to NowThis World: http://go.nowth.is/World_Subscribe The First Amendment protects free speech, but there are some exceptions. How annoying can you be before it becomes illegal? Learn More: There's Actually Free Speech Zones http://www.cnn.com/2012/09/02/politics/rnc-protest-vermin-supreme/index.html?iref=allsearch First Amendment: An Overview http://www.law.cornell.edu/wex/first_amendment "The First Amendment of the United States Constitution protects the right to freedom of religion and freedom of expression from government interference." Who is the Reasonable Person? http://www.lclark.edu/live/files/7230-lcb144art1moranpdf "As the common law's most enduring fiction, the reasonable person fulfills a great many different roles across very different bodies of law." Harassment http://definitions.uslegal.com/h/harassment/ "Harassment is governed by state laws, which vary by state, but is generally defined as a course of conduct which annoys, threatens, intimidates, alarms, or puts a person in fear of their safety." Reasonable Person http://definitions.uslegal.com/r/reasonable-prudent-man/ "Reasonable or Prudent man is a hypothetical person used as a legal standard especially to determine whether someone acted with negligence." Watch More: Is Online Trolling Illegal? https://www.youtube.com/watch?v=vdVJ2L8SabU _________________________ NowThis World is dedicated to bringing you topical explainers about the world around you. Each week we’ll be exploring current stories in international news, by examining the facts, providing historical context, and outlining the key players involved. We’ll also highlight powerful countries, ideologies, influential leaders, and ongoing global conflicts that are shaping the current landscape of the international community across the globe today. More from NowThis: » Subscribe to NowThis News: http://go.nowth.is/News_Subscribe » Like NowThis World on Facebook: https://go.nowth.is/World_Facebook » Connect with Judah: Follow @judah_robinson on Twitter – Facebook: http://go.nowth.is/LikeJudah » Connect with Versha: Follow @versharma on Twitter – Facebook: http://go.nowth.is/LikeVersha http://www.youtube.com/nowthisworld
Просмотров: 106874 NowThis World
Top 7 Type 2 Diabetes Medications
Some people who have type 2 diabetes can achieve their target blood sugar levels with diet and exercise alone, but many also need diabetes medications or insulin therapy. The decision about which medications are best depends on many factors, including your blood sugar level and any other health problems you have. Your doctor might even combine drugs from different classes to help you control your blood sugar in several different ways. 1. Metformin Generally, metformin is the first medication prescribed for type 2 diabetes. It works by improving the sensitivity of your body tissues to insulin so that your body uses insulin more effectively. Metformin also lowers glucose production in the liver. Metformin may not lower blood sugar enough on its own. Your doctor will also recommend lifestyle changes, such as losing weight and becoming more active. 2. Meglitinides These medications work like sulfonylureas by stimulating the pancreas to secrete more insulin, but they're faster acting, and the duration of their effect in the body is shorter. They also have a risk of causing low blood sugar, but this risk is lower than with sulfonylureas. Weight gain is a possibility with this class of medications as well. Examples include repaglinide (Prandin) and nateglinide (Starlix). 3. Thiazolidinediones Like metformin, these medications make the body's tissues more sensitive to insulin. This class of medications has been linked to weight gain and other more-serious side effects, such as an increased risk of heart failure and fractures. Because of these risks, these medications generally aren't a first-choice treatment. Rosiglitazone (Avandia) and pioglitazone (Actos) are examples of thiazolidinediones. 4. Sulfonylureas These medications help your body secrete more insulin. Examples of medications in this class include glyburide (DiaBeta, Glynase), glipizide (Glucotrol) and glimepiride (Amaryl). Possible side effects include low blood sugar and weight gain. 5. GLP-1 receptor agonists These medications slow digestion and help lower blood sugar levels, though not as much as sulfonylureas. Their use is often associated with some weight loss. This class of medications isn't recommended for use by itself. Exenatide (Byetta) and liraglutide (Victoza) are examples of GLP-1 receptor agonists. Possible side effects include nausea and an increased risk of pancreatitis. 6. SGLT2 inhibitors These are the newest diabetes drugs on the market. They work by preventing the kidneys from reabsorbing sugar into the blood. Instead, the sugar is excreted in the urine. Examples include canagliflozin (Invokana) and dapagliflozin (Farxiga). Side effects may include yeast infections and urinary tract infections, increased urination and hypotension. 7. DPP-4 inhibitors These medications help reduce blood sugar levels, but tend to have a modest effect. They don't cause weight gain. Examples of these medications are sitagliptin (Januvia), saxagliptin (Onglyza) and linagliptin (Tradjenta).
Просмотров: 263474 Diabetes zone
Making Drugs Cheaper Without Stifling Innovation -- Euro Style
Can we keep drug prices low without hurting innovation? Well, drugs are a lot cheaper in Europe than in the US, and there's still plenty of innovation over there. So what's going on? It's called reference pricing, and it's pretty much genius. Those of you who want to read more can go here: http://theincidentaleconomist.com/wordpress/?p=72475 John Green -- Executive Producer Stan Muller -- Director, Producer Aaron Carroll -- Writer Mark Olsen -- Graphics http://www.twitter.com/aaronecarroll http://www.twitter.com/crashcoursestan http://www.twitter.com/johngreen http://www.twitter.com/olsenvideo And the housekeeping: 1) You can support Healthcare Triage on Patreon: http://vid.io/xqXr Every little bit helps make the show better! 2) Check out our Facebook page: http://goo.gl/LnOq5z 3) We still have merchandise available at http://www.hctmerch.com
Просмотров: 39241 Healthcare Triage
The Pros and Cons of Regulating Drug Prices
Dr. Steven Miller and Dr. Peter Bach discuss
Просмотров: 473 Fortune Magazine
What's behind prescription drug price hikes
Prescription drug costs are skyrocketing and it’s causing sticker shock at the pharmacy. These are drugs that have been around for years. The medications haven't changed, but the price tags have, and manufacturers don’t have to explain the markup.
Просмотров: 81 NBC 26
Special Focus On Generic Medicines| Difference Between Generic & Branded Medicines | TV5 News
Watch TV5 Special Focus on The Differences Between Generic Medicines and Branded Medicines. Generic Medicines are the Cheapest Medicines with Same Formula of which the branded medicines were made. The Price Range difference between Generic and Branded Medicines is almost 50 percent high. To Know More, Watch The Video. For More Updates ► TV5 News Live http://bit.ly/1PRDdQv ► Subscribe to TV5 News Channel: http://goo.gl/NHJD9 ► Download TV5 Android App: http://goo.gl/8mMEOX ►Our Website : http://www.tv5news.in ► Like us on Facebook: http://www.facebook.com/tv5newschannel ► Follow us on Twitter: https://twitter.com/tv5newsnow ► Circle us on TV5 News Channel G+: https://plus.google.com/+tv5newschannel ► Follow us on Pinterest: https://www.pinterest.com/tv5newschannel TV5 news is a 24 hours Telugu News Channel covering politics, sports, health, lifestyle and entertainment. TV5 news has 24 hours of news programs including Telugu news live, hourly news updates, Telangana news, Andhra Pradesh news updates, weather reports, exclusive interviews with celebrities, politicians and social activists and all important news updates from around the World
Просмотров: 8327 TV5 News
Medicine Actual Price
Actual Price for Normal medicine
Просмотров: 180 Health Flicks
A07 Pharma Pricing Control
Pharmaceutical Pricing Controls. This will be the beginning of getting Prescription drug costs under control.
Просмотров: 6 CS2News
End the Price Gouging for Needed Medication
Senator Bob Huff (R-San Dimas) rises to support Senate Joint Resolution (SJR) 29, which urges the Food and Drug Administration (FDA) to reconsider its denial of approval for generic alternatives to the epinephrine auto-injector EpiPen and urges Congress to investigate the impact that Mylan’s monopoly has had on price increases for EpiPen. Senator Huff represents the 29th Senate District covering portions of Los Angeles, Orange and San Bernardino Counties. Follow Senator Huff on Twitter @bobhuff99.
Просмотров: 22 Bob Huff
Big Pharma price fixing
The inside story of a price fixing buy an American drug company Valeant.
Просмотров: 64 John Linkletter
RXSchool Episode 16 - MAC Pricing in the pharmacy business
Many independent pharmacies are put out of business as the reimbursement for generic drugs decreased over time due to the MAC pricing method used by PBMs. This video will define what MAC is , and how it is used by PBMs to generate money and the recent changes in the pharmacy industry.
Просмотров: 294 RXSchool
Tv9 IMPACT : Low-cost medicines at a generic drug store will be available soon
► Watch #TV9GujaratiLIVE : https://goo.gl/JNz8zj ► Subscribe TV9 Gujarati: https://goo.gl/2PezmD ► Circle us on G+: https://plus.google.com/+tv9gujarat ► Like us on Facebook: https://www.facebook.com/tv9gujarati ► Follow us on Twitter: https://twitter.com/Tv9Gujarati ► Follow us on Dailymotion: http://www.dailymotion.com/GujaratTV9 ► Pin us on Pinterest: https://www.pinterest.com/tv9gujarati
Просмотров: 288 Tv9 Gujarat
55% slash in prices of BP, cancer, diabetes drugs
The prices of 54 essential medicines has been slashed down by up to 55% by Drug price regulator Pharmaceutical Pricing authority (NPPA). Theses medicines include drugs for cancer (brain and breast), hypertension, diabetes and other heart disorders.
Просмотров: 480 NYOOOZ TV
The Naked Truth: Access to Medicines
Meet Bob. Challenge Bob and demand affordable medicines for everyone, everywhere. Our governments, meeting now at the UN General Assembly, have the power to change the future of medical research. #UNGA http://livesontheedge.msf.org/ https://twitter.com/MSF_USA Our in-depth report, Lives on the Edge, shines a light on the lives damaged by the way pharmaceutical research and development is conducted, and the failure of governments to fix the problem. In many cases,drug corporations have successfully lobbied governments to block reforms or even make things worse.
Просмотров: 1788 Doctors Without Borders / MSF-USA
Rising prescription drug prices
The cost of prescription drugs is on the rise - and that has caught the eye of some high level people, including U. S. Senator Richard Blumenthal.
Просмотров: 89 Hartford HealthCare
Medical Shop in Kolkata - Dipti Pharmacy
Dipti Pharmacy is one of the leading Medical Shops in Kolkata offer best medicine at best price. We offer satisfactory facilities and polyclinic with years of experience. For more details visit http://www.diptipharmacy.in/ Contact Address: 962 (C-276) Survey Park, Kolkata - 700075 Tel: +91 9432849515
Просмотров: 15098 Dipti Pharmacy
McKinsey: Africa pharma sector worth $65 billion by 2020
Africa's pharmaceutical industry is among the fastest-growing industries globally. It's expanded from $4.7 billion to $20.8 billion in a period of ten years. Mckinsey predicts the market will be worth up to $65 billion by 2020 -- but Africa needs to make a bigger contribution to this process. Analysts estimate that by 2017, the need for prescription medicine, generics, over-the-counter drugs and medical devices on the continent will grow by up to 11%. Catalyst Principal Partners, a leading East African focused private equity firm, has acquired a controlling stake in Zenufa Laboratories in Tanzania. Though the healthcare sector in the country is dominated by foreign imports, the company chose to invest in an established local firm. Zenufa is the second largest local pharmaceutical generics manufacturer in Tanzania.
Просмотров: 1851 CGTN Africa
Algeria produces own medicines to cut import bill
(8 Aug 2016) LEAD IN: Algeria is turning to locally produced medication to save money. Ninety percent of its pharmaceuticals used to come from overseas, according to Algerian drugs producers. But they're now aiming for a dramatic cut in imports. STORY-LINE: Medicine stocks are changing at pharmacies in Algeria. The country is turning away from expensive imports and instead producing its own drugs. And pharmacist Amir Gor thinks Algerian-made generic medicines could become even more popular - if a few changes are made. "They have to improve the quality of medicines to gain the confidence of customers," he says. "We have never had so many generic drugs as we do today. It's going well but they also need to have a variety. It's not necessary to produce 10 copies of the original one, they should cover the Algerian market," he adds. And there are substantial savings for customers. For example, anti-inflammatory drug Profenid costs around 628 Moroccan Dinars (5.69 US dollars), while its generic alternative produced in Algeria, Ketonal, costs just 282 Dinars (2.55 US dollars). "I don't feel any difference between the original and the generic medicine," says pharmacy customer Abdou Kechida. Algeria's medicine market is worth around 3 billion US dollars and the oil-producing nation previously relied heavily on imports, bringing 90 percent of its drugs in from overseas suppliers. But as oil prices have tumbled, the government has been forced to cut its import bill. Two billion US dollars is now spent on medicine imports, while the market for drugs produced domestically accounts for one billion, according to government news agency APS. So companies like El Kendi are being encouraged to make more generic drugs. Other countries have embraced local drug production, with India's pharmaceutical sector now supplying affordable, generic medicines for conditions such as HIV, TB and malaria to patients across Africa. El Kendi's strategy developer Abdoullah Belkroun say generic drugs are common in underdeveloped countries for financial reasons. "It gives us the opportunity to produce more innovative drugs when we can not support high costs," he says. Algeria now imports 60 percent of the drugs it uses. But El Kendi's CEO thinks there is room for improvement. "We promise Algerians to contribute to decreasing the importation to under 50 percent in the next two years," says Essam Farouk. And if they succeed, not only will the country save money - Algeria's pharmaceutical industry will get a serious boost. You can license this story through AP Archive: http://www.aparchive.com/metadata/youtube/ecdcb08a3061f51e94e0bc02ea7132d8 Find out more about AP Archive: http://www.aparchive.com/HowWeWork
Просмотров: 276 AP Archive
Why Are We Paying $300 for an EpiPen That Holds Only $1 Worth of Medicine?
http://democracynow.org - In 2007, the wholesale price of the EpiPen in the U.S. was $57. Less than a decade later, the life-saving drug now costs over $300. Each EpiPen reportedly contains only $1 worth of medicine. Mylan has a near monopoly in the U.S., and the company has seen its profits from the EpiPen alone skyrocket to $1 billion a year. Meanwhile, Mylan CEO Heather Bresch’s total compensation has spiked from around $2.5 million in 2007 to almost $19 million today. In response to the price hikes, the consumer advocacy group Public Citizen and its allies will deliver a petition signed by approximately 600,000 people to Mylan’s headquarters in Canonsburg, Pennsylvania, today demanding further price cuts. For more, we speak with Peter Maybarduk, director of Public Citizen’s Global Access to Medicines Program. And we speak with Ashley Alteman, who runs a website called SmashleyAshley.com, where she has just posted an open letter to Mylan CEO Heather Bresch. Democracy Now! is an independent global news hour that airs weekdays on nearly 1,400 TV and radio stations Monday through Friday. Watch our livestream 8-9AM ET: http://democracynow.org Please consider supporting independent media by making a donation to Democracy Now! today: http://democracynow.org/donate FOLLOW DEMOCRACY NOW! ONLINE: Facebook: http://facebook.com/democracynow Twitter: https://twitter.com/democracynow YouTube: http://youtube.com/democracynow SoundCloud: http://soundcloud.com/democracynow Daily Email: http://democracynow.org/subscribe Google+: https://plus.google.com/+DemocracyNow Instagram: http://instagram.com/democracynow Tumblr: http://democracynow.tumblr.com Pinterest: http://pinterest.com/democracynow iTunes: https://itunes.apple.com/podcast/democracy-now!-audio/id73802554 TuneIn: http://tunein.com/radio/Democracy-Now-p90/ Stitcher Radio: http://www.stitcher.com/podcast/democracy-now
Просмотров: 8582 Democracy Now!
Prescription Drug Prices Soar
Lawmakers in Congress are trying to find out why prescription drug prices have gone up by 76% since 2010. A former executive who raised the price of a potentially life-saving drug by 5000% pleaded the 5th today during a hearing on Capitol Hill.
Просмотров: 481 Fox News
Branded Vs. Generic Drugs - TV9
Branded Vs. Generic ► Download Tv9 Android App: http://goo.gl/T1ZHNJ ► Subscribe to Tv9 Telugu Live: https://goo.gl/lAjMru ► Circle us on G+: https://plus.google.com/+tv9 ► Like us on Facebook: https://www.facebook.com/tv9telugu ► Follow us on Twitter: https://twitter.com/Tv9Telugu ► Pin us on Pinterest: https://www.pinterest.com/Tv9telugu
Просмотров: 9360 TV9 Telugu
Understanding Specialty Drug Pricing | Benefit Bits
Industry thought leader Brian Seiz discusses how plans can use information to better control specialty drug spending while he was in attendance at the US Annual Employee Benefits Conference. For more about the US Annual Conference, visit: http://www.ifebp.org/usannual For more Benefit Bits, visit: http://www.ifebp.org/benefitbits
Просмотров: 304 IFEBP
Sticker Shock  What is the Antidote for High Cost Drugs
What is fueling the skyrocketing price increases for lifesaving drugs such as Epipen, Daraprim and some specialty drugs? Are there benefit changes to consider when facing prescription drug costs that seem to increase by 100% - 500% overnight? Learn how to take advantage of potential cost savings with the release of an “authorized generic” by a brand drug manufacturer and how to “take the fight” to PBMs on biosimilar rebates. Join Greg Madsen and Michael Staab for an eye-opening one hour webinar and determine what you can do to get prescription drug costs under control.
Prescription Drug Prices Outpaced Inflation in 2015
Prescription drugs commonly used by the elderly are on the rise, but only in price. According to a new study, the price of brand-name drugs rose 130-times faster than the inflation rate over the last year. Researchers examined the prices of hundreds of branded prescription drugs used by seniors, including entire drug categories used to treat high blood pressure, high cholesterol and diabetes. The data compiled in the report shows that retail prices rose an average of 15.5-percent in 2015. http://www.upi.com/Health_News/2016/12/14/Prices-soar-on-drugs-widely-used-by-seniors-Report/6241481740335/ http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Просмотров: 82 Wochit News
If India caves in to pressure to stop supplying Africa with affordable ARVs, the results could…
International aid organization Doctors Without Borders (MSF) said India should not cave in to the continuing corporate pressure to stop supplying affordable, generic medicines to millions of people in South Africa and the rest of the continent. The call was made on the sidelines of Indian Prime Minister Narendra Modi’s first state visit to South Africa. South Africa imports the highest volume of its medicines from India – including life-saving antiretrovirals for HIV, and treatments for a wide… READ MORE : http://www.africanews.com/2016/07/07/if-india-caves-in-to-pressure-to-stop-supplying-africa-with-affordable-arvs-the Africanews is a new pan-African media pioneering multilingual and independent news telling expertise in Sub-Saharan Africa. Subscribe on ourYoutube channel : https://www.youtube.com/c/africanews Africanews is available in English and French. Website : www.africanews.com Facebook : https://www.facebook.com/africanews.channel/ Twitter : https://twitter.com/africanews
Просмотров: 159 africanews
Prescription Drug Pricing: New Solutions
Experts from the pharmaceutical, government, academic, medical and health care arena gather at the Johns Hopkins Bloomberg School of Public Health for a symposium on Prescription Drug Pricing. The half day event brings together leaders from the private and public sector with a wide range of perspectives to discuss and formulate policy options to address the prescription drug pricing issue in the U.S.
Mobile App | For Generic Medicine | List 1
For more info log on to www.24taas.com Like us on https://www.facebook.com/Zee24Taas Follow us on https://twitter.com/zee24taasnews
Просмотров: 195 ZEE 24 TAAS
Falls Community Hospital & Clinic Receive Tribute & Free Medication Help by ACRX
http://www.genericmedication.news - American Consultants Rx Inc. works hard to supply much needed assistance to consumers who are looking for a way to cut costs on prescription drug ,medical and life insurance cost .Due to the rising costs,unstable economics,and the mounting cost of prescription drug cost , American Consultants Rx Inc.(a.k.a ACRX & ACIRX) an Atlanta based company was born in 2004. Since the creation of the American Consultants Rx discount prescription card program, over thirty million discount prescription cards have been donated to over thirty five thousand organizations.Organizations have utilized this program in an effort to assist the uninsured in the communities in dealing with the high cost of prescription drugs with savings as high as 80% off. As an additional request from doctors,clinics, and social welfare directors across the country the ACRX cards can also be downloaded installing the ACRX app designed for Android users,or by visiting our website (All organizations are encouraged to take advantage of this option in an effort to assist their community at http://acrxnews.com and printing or requesting a card that is already pre-activated. . All pharmacies involved will honor a copy of the ACRX card. We have also made new arrangements now available in English and Español where any individual can discover what the cost of their medicine will be with the card as well as what store in their area offers the best discount. As an added bonus the free ACRX cards can now be used for PETS! Just ask your veterinarian if your pet's medicine can be filled at the local pharmacy.If so just ask your veterinarian for a prescription.Then just present your pets prescription and your ACRX card at the time of purchase and save!
Просмотров: 1 Generic Medication News
🛍 10/10 the BEST and WORST Generic V Brand products to save you CASH!
Take the guess work out of your decision on whether or not to buy Generic. The Deal Guy has you covered, from medication to Food to electronics, Matt Granite runs through the ones to take advantage of and the ones to avoid. ↓↓ See below for the DEAL LINKS FOR TODAY ↓↓ FOR FREEBIES & DEALS, CLICK ► http://www.YouTubeDeals.com How to turn on your alerts to get deals first ► http://bit.ly/1UrqRn0 ► Compare Generic Prescription Drugs On Sale: http://www.goodrx.com/ ► Amazon Basics Lightning Cables On Sale: http://amzn.to/2d5N7ik ► iClever 3 Port Boost Cubes On Sale Today: http://amzn.to/2d1zjdT ► Non-Prime Members score free shipping with this 30 day Amazon Prime: http://amzn.to/29pZBiX GET MORE IN STOCK DEALS: https://goo.gl/Jim54z Take the advice from the Deal Guy on the Best and Worst generic products, on which ones to avoid and which to take advantage of. This advise will save you cash all year round. Whether it comes from Science for you health of food products. When a generic drug product is approved, it has met rigorous standards established by the FDA with respect to identity, strength, quality, purity, and potency. However, some variability can and does occur during manufacturing, for both brand name and generic drugs. When a drug, generic or brand name, is mass-produced, very small variations in purity, size, strength, and other parameters are permitted. FDA limits how much variability is acceptable. Generic drugs are required to have the same active ingredient, strength, dosage form, and route of administration as the brand name product. Generic drugs do not need to contain the same inactive ingredients as the brand name product. The generic drug manufacturer must prove its drug is the same as (bioequivalent) the brand name drug. For example, after the patient takes the generic drug, the amount of drug in the bloodstream is measured. If the levels of the drug in the bloodstream are the same as the levels found when the brand name product is used, the generic drug will work the same. Through review of bioequivalence data, FDA ensures that the generic product performs the same as its respective brand name product. This standard applies to all generic drugs, whether immediate or controlled release. All generic health Pharmacology manufacturing, packaging, and testing sites must pass the same quality standards as those of brand name drugs, and the generic products must meet the same exacting specifications as any brand name product. In fact, many generic drugs are made in the same manufacturing plants as brand name drug products. TWITTER: http://www.twitter.com/mattgranite FACEBOOK: http://www.facebook.com/wtsmattgranite Some of the links used on this YouTube Channel have Bitly performance tracking codes, some are from third parties, and in some cases affiliate links. While third parties and YouTube advertisers benefit directly, the talent on this channel (including interns) do not make a commission.
Просмотров: 4303 The Deal Guy
Fill Your Scripts Without Breaking the Bank
Get ready to save money on your prescription drugs! Prescription drug costs, including generic drugs, continue to rise! But there is a way you can keep more money in your pocket. Jerry Parker and Shawn Ohri join us with details on ScriptSave WellRx. This program requires no enrollment fee, offers instant savings at the register on both brand name and generic prescription medications, and is accepted at more than 62,000 participating chain and independent retail pharmacies nationwide. We're talking saving averaging 44-percent, with potential savings up to 75-percent! And you can use the program to save on prescriptions for everyone in your household - including your pets! You can use the program whether or not you have health insurance. Employers and organizations can offer the program to their employees and members as a value-added service too! Want to see how it works? Check it out on The Balancing Act! You don't want to miss this! Visit: http://www.thebalancingact.com Like: https://www.facebook.com/TheBalancingActFans Follow: https://twitter.com/BalancingActTV #TheBalancingAct #BalancingAct 103223
Просмотров: 124 TheBalancingAct
The High Cost of Collusion: Why Health Care is So Expensive in the US
See: http://truecostofhealthcare.net/
Просмотров: 3888 David Belk
Anna Sanjeevani Generic Medicine Gets Good Response Across State| A Report
Anna Sanjeevani Generic Medicine Gets Good Response Across State| A Report ---------------------------------------------------------------------------------------------- ☛ Download ETV Android App: https://goo.gl/aub2D9 For Latest Updates on ETV Channels !! ☛ Visit our Official Website: http://www.etv.co.in ☛ Subscribe to Latest News -https://goo.gl/9Waw1K ☛ Subscribe to our YouTube Channel - http://bit.ly/JGOsxY ☛ Like us : https://www.facebook.com/ETVAndhraPradesh ☛ Follow us : https://twitter.com/etvandhraprades ☛ Circle us : https://goo.gl/H5cc6E ----------------------------------------------------------------------------------------------
Просмотров: 3904 ETV Andhra Pradesh
Talking Point : Dr G N Singh, Drug Controller General of India
Talking Point : Dr G N Singh, Drug Controller General of India टॉकिंग पॉइंट
Просмотров: 2351 Lok Sabha TV
BPPI - Running 10 Years of Historical UK Drug Tariff Reimbursement Prices
This video shows how user can run and download 10 years of reimbursement prices from the UK. This included UK Generic Drug Tariffs, Brand List Prices and Generic NCSO prices (no cheaper stock obtainable).
Просмотров: 98 Charles Joynson
Price Curbs Hurting Indian Pharma Companies
The government’s drug price controls have hurt domestic sales growth of Indian pharmaceutical companies, some of whom are already facing the brunt of regulatory actions by the U.S. regulator (U.S. FDA). Read more about this on BloombergQuint: http://www.bloombergquint.com/charts/2016/08/22/price-curbs-hurt-domestic-revenue-growth-of-indian-pharma-companies Read more of Markets News here: http://www.bloombergquint.com/section/markets Read more articles by Shraddha Babla at: http://www.bloombergquint.com/author/44708/shraddha-babla
Просмотров: 67 BloombergQuint
Pfizer in record £84 million fine over drug price hikes
DescriptionPharma giant Pfizer was on Wednesday slapped with the biggest penalty imposed by Britain’s competition watchdog, an £84 million fine for charging the NHS “excessive and unfair prices” for a key anti-epilepsy drug. Pfizer, the US drugmaker “deliberately… hike[d] up the price for a drug which is relied upon by many thousands of patients”, the Competition and Markets Authority said. In 2012, Viagra-maker Pfizer stripped its epilepsy drug Epanutin of its branding, turning it into a generic medicine, phenytoin sodium, as these are not subject to price regulation. It then sold the licence to British drugs distributor Flynn Pharma, which was today fined £5.2 million for its role in the scandal. The pair broke competition law with a crucial medicine for some 48,000 UK patients, the CMA found. They hiked the price of a 100mg packet of pills by 2600% “overnight” from £2.83 to £67.50 in September 2012. NHS spending on the capsules shot up from £2 million to £50 million in 12 months as a result. Pfizer’s pricing for the same drug in other European countries remained far lower. As epilepsy patients on certain drugs should not usually be switched to others, due to serious health consequences, “the NHS had no alternative to paying the increased prices for the drug”, the CMA said. Pfizer and Flynn Pharma, which calls the capsules a “vitally important product” on its website, “abused [their] dominant position by charging excessive and unfair prices”, the CMA said of its record fine. Boss Pfizer Ian Read claimed NHS patients would benefit from “better products, faster” during his £69 billion attempt to buy AstraZeneca in 2014. The next-biggest penalty was a £45 million fine on GlaxoSmithKline and other drugmakers in February. The CMA has also ordered Pfizer and Flynn to drop their prices, giving them up to four months to do so. In September 2012, a Flynn company director claimed “for us to continue to make the drug available in the UK, we had to [hike the price],” while Pfizer had claimed it was making Epanutin at a loss, but couldn’t stop doing so as patients relied on it. However, CMA research showed any losses would have been recovered within two months of the price rises. Pfizer said it will “be appealing all aspects” of its fine. Flynn said the ruling was based on a “wholly flawed understanding” of the drugs market.
Просмотров: 156 Shoeb Kabir
Helpful tips on disposing of prescription drugs
With drug addiction and opioid abuse making national headlines, it’s not surprising this year’s Drug Take Back Day has captured the attention of our local news outlets. Our vice president of pharmacy management shares some poignant statistics and helpful tips on disposing of prescription drugs with Good Morning Arizona. Watch this clip to learn more about what you can do.
Просмотров: 90 Blue Cross Blue Shield of Arizona
Allergan CEO: These drug price increases have to stop
Allergan CEO Brent Saunders on the pharmaceutical company's third-quarter results, the company's drug pipeline, drug pricing and the election's impact on corporate taxes.
Просмотров: 550 Fox Business
Govt. launches mobile app 'Pharma Sahi Daam' to help customers to know price of medicines
Chemicals and Fertiliser Minister Ananth Kumar said Government will amend Drugs Prices Control norms in 15 days for capping prices of 350 new drugs and also also launched mobile app 'Pharma Sahi Dhaam' to show drug prices ‘DD News’ is the News Channel of India's Public Service Broadcaster 'Prasar Bharati'. DD News has been successfully discharging its responsibility to give balanced, fair and accurate news without sensationalizing as well as by carrying different shades of opinion. Follow DD News on Twitter (English): https://twitter.com/ddnewslive Twitter (Hindi):https://twitter.com/DDNewsHindi Face Book: https://www.facebook.com/DDNews Visit DD News Website (English): www.ddinews.gov.in Visit DD News Website (Hindi): http://ddinews.gov.in/Hindi/
Просмотров: 298 DD News
Generic Drugs fail to reach common man || Panelists Sukumar and Vinod || Business Prime Time - TV9
Generic Drugs fail to reach common man || Panelists Sukumar and Vinod || Business Prime Time ► Download Tv9 Android App: http://goo.gl/T1ZHNJ ► Subscribe to Tv9 Telugu Live: https://goo.gl/lAjMru ► Circle us on G+: https://plus.google.com/+tv9 ► Like us on Facebook: https://www.facebook.com/tv9telugu ► Follow us on Twitter: https://twitter.com/Tv9Telugu ► Pin us on Pinterest: https://www.pinterest.com/Tv9telugu
Просмотров: 640 TV9 Telugu
Study Says Overuse of Brand-Name Drugs is Costing U.S. Billions
A new study says overuse of brand-name drugs may be part of the reason why the United States spends more on medication than any other country. Researchers say too many brand-name drugs also contribute to greater out-of-pocket expenses for American consumers. For the study, the researchers reviewed self-reported prescription drug use by more than 107,000 Americans who were part of the 2010-2012 Medical Expenditure Panel Survey. Researchers found that $760 billion was spent on prescription drugs during the study and nearly 10 percent of all prescription drug expenses involved brand-name drug overuse. http://www.upi.com/Health_News/2016/05/09/Cutting-brand-name-drug-use-could-save-US-73-billion-Study/2931462830346/ http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Просмотров: 77 Wochit News
Are hospital pharmacies cheating the patients?
Просмотров: 184 WetheVoice Online
Greedy Pharma Execs Don’t Care If You Live Or Die - The Ring Of Fire
The Mylan Pharmaceutical price hike story is just one of many instances of Big Pharma executives putting profits ahead of people. Every major pharmaceutical company in America does the same thing, and it all has to do with their greed. Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Order Mike Papantonio's new novel Law and Disorder today: https://www.amazon.com/Law-Disorder-Mike-Papantonio/dp/1590793676 Follow more of our stories at http://www.TROFIRE.com Subscribe to our podcast: http://www.ROFPodcast.com Support Ring of Fire by subscribing to our YouTube channel: http://www.youtube.com/user/golefttv Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Instagram: https://www.instagram.com/ringoffirenetwork/
Просмотров: 3981 The Ring of Fire
Missing Drugs from Karunya Pharmacy | Asianet News Exclusive
Kerala govt purchased generic drugs found sub-standard so Medical services corporation moving to destroying this drugs Missing Drugs from Karunya Pharmacy | Asianet News Exclusive Click Here To Free Subscribe! ► http://goo.gl/Y4yRZG Website ► http://www.asianetnews.tv Facebook ► https://www.facebook.com/AsianetNews Twitter ► https://twitter.com/asianetnewstv Pinterest ► http://www.pinterest.com/asianetnews Vine ► https://www.vine.co/Asianet.News
Просмотров: 717 asianetnews
Drugs price hike in medical store: Drugs control department keep silence | Manorama News
Drugs price hike in medical store: Drugs control department keep silence The official YouTube channel for Manorama News. Manorama News, Kerala’s No. 1 news and infotainment channel, is a unit of MM TV Ltd., Malayala Manorama’s television venture. Manorama News was launched on August 17, 2006. The channel inherited the innate strengths of the Malayala Manorama daily newspaper and its editorial values: accuracy, credibility and fairness. It raised the bar in Malayalam television news coverage and stands for unbiased reporting, intelligent commentary and innovative programs. MM TV has offices across the country and overseas, including in major cities in Kerala, Metros and in Dubai, UAE. Subscribe us to watch the missed episodes. Subscribe to the #ManoramaNews YouTube Channel https://goo.gl/EQDKUB Get #ManoramaNews Latest news updates http://goo.gl/kCaUpp Visit our website: www.manoramanes.com http://goo.gl/wYfPKq Follow #ManoramaNews in Twitter https://goo.gl/tqDyok Watch the latest #ManoramaNews News Video updates and special programmes: https://goo.gl/63IdXc Watch the latest Episodes of #ManoramaNews #Nattupacha https://goo.gl/KQt2T8 Watch the latest Episodes of #ManoramaNews #ParayatheVayya https://goo.gl/C50rur Watch the latest Episodes of #ManoramaNews #NiyanthranaRekha https://goo.gl/ltE10X Watch the latest Episodes of #ManoramaNews #GulfThisWeek https://goo.gl/xzysbL Watch the latest Episodes of #ManoramaNews #ThiruvaEthirva https://goo.gl/2HYnQC Watch the latest Episodes of #ManoramaNews #NereChowe https://goo.gl/QWdAg2 Watch the latest Episodes of #ManoramaNews #Fasttrack https://goo.gl/SJJ6cf Watch the latest Episodes of #ManoramaNews #Selfie https://goo.gl/x0sojm Watch the latest Episodes of #ManoramaNews #Veedu https://goo.gl/enX1bV
Просмотров: 768 Manorama News
Sale of banned medicines still active in medical stores [ MediaOne Investigation]
more news: www.mediaonetv.in watch live: www.mediaonetv.in/watch
Просмотров: 561 MediaoneTV Live
today on various dimensions in the Indian pharmaceutical sector. Firstly, the issue is on intellectual property. The second issue that we will deliberate on quality issues on medicines coming out from Indian pharmaceutical sector. The third issue that we would like to touch on about events that are happening today in the sector relates to innovation and entrepreneurship. So, let me try to go through each of these three issues one by one. What about intellectual property? Well, the Indian pharmaceutical industry has evoked very empathetic reactions from all around the world for over more than two decades supplying generic medicines globally and thereby helping nations to reduce the cost of medicines and the importance of medicinal costs in the overall healthcare budgets of countries. If you look at the export orientation of Indian pharmaceutical sector, you will see that they go to more than 200 countries in terms of exporting medicines. They sell all kinds of products starting from depression pills to hypertension drugs and they also focus on diseases of the rich as well as of the poor. But, that being said, they also raise some thorny issues, and the key thorny issue that they raise is related to this debate on access versus innovation. The global biopharmaceutical industry, especially the innovator-originator firms like the Pfizers and the Eli Lillys and the GlaxoSmithKlines will argue, if you talk to them, that the Indian pharmaceutical industry is a pirate. It basically reverse engineers drugs, free rides on intellectual property generated by them, and sell generic medicines at low prices, not just domestically in India, but globally around the world. The Indian pharmaceutical industry will then argue back saying that, "Hey, originator, maybe you don't deserve to have that kind of price of the drug, even if you have innovated on that drug.” Now, this is raising a key issue in the economics of innovation which is that, do you need stronger intellectual property for incentivizing innovation? And if you look at research on this story, yes, you do need incentives for innovation to incentivize the inventor. If you don't have stronger intellectual property, the inventor will never come up with the science and innovation to come up with the new drug and that is what the argument, the global biopharmaceutical firms are arguing with. That being said, it is also true that monopoly pricing, if you give intellectual property, you entail that there is some monopoly pricing that is offered to the originator-innovator firms will ensure that pharmaceutical prices will remain out of the access of the larger citizenry. Now, is that fair? Well, that's exactly where the discussion and debate starts related to intellectual property in Indian pharmaceuticals. It is probably not completely fair, neither is it completely unfair. The truth lies somewhere in between. At one end it is true that you cannot free ride on somebody's intellectual property but at the other end, you cannot always give the excuse of free riding or access and affordability to continually do reverse engineering, especially when you have done reverse engineering for over three to four decades. So, you need to have a nuanced view on the debate related to intellectual property. One of the key pharmaceutical firms who started this discussion on intellectual property in Indian pharmaceutical industry was Cipla, when it came up with this three drug combination in HIV drugs that was being sold at around 200 dollars, which is like 1 by 50th of the originated drug that was being sold at 10,000 dollars. And that created a huge global ripple with that kind of a disruption effect. Now, over time there are several other companies like Dr. Reddy's, Ranbaxy’s, and others which you might not know who have come out with the capabilities that are required to reverse engineer drugs. That being said, they are also having a leg in terms of explorative discovery capabilities. Have they performed well on that? Not really. If you look at Dr. Reddy's product called balaglitazone which was originated around the mid-1990s, what essentially happened was Dr. Reddy's didn’t have the wherewithal to take it all the way to launch the drug in the market and therefore it had out-license balaglitazone to a Danish company called Novo Nordisk. And, therefore, the broader story that comes out of Indian pharmaceutical industry is that they continue to do generics, they continue to reverse engineer, and they continue to hope that disruption will actually help them give a leg up in this product debate around access versus innovation.
Просмотров: 299 Gaurav Kumar Sharma